Cargando…
The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis
BACKGROUND: The chemokine CXCL13 has been discussed as a diagnostic parameter with high specificity for Lyme neuroborreliosis (LNB) and as a marker of disease activity. Neurosyphilis and LNB share similar characteristics. We investigated retrospectively CXCL13 levels in the cerebrospinal fluid (CSF)...
Autores principales: | Dersch, R, Hottenrott, T, Senel, M, Lehmensiek, V, Tumani, H, Rauer, S, Stich, O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489031/ https://www.ncbi.nlm.nih.gov/pubmed/25975424 http://dx.doi.org/10.1186/s12987-015-0008-8 |
Ejemplares similares
-
The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
por: Brettschneider, Johannes, et al.
Publicado: (2010) -
CXCL13 and TH1/Th2 cytokines in the serum and cerebrospinal fluid of neurosyphilis patients
por: Yan, Yongxing, et al.
Publicado: (2017) -
The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis
por: Henningsson, Anna J., et al.
Publicado: (2018) -
Increased CCL24 and CXCL7 levels in the cerebrospinal fluid of patients with neurosyphilis
por: Li, Xin‐Xin, et al.
Publicado: (2020) -
CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients
por: Zeng, Yan-Li, et al.
Publicado: (2016)